
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| AL_L | 2,262 | 99.8% | 2.88 | 16,614 | 99.9% |
| VES_L | 4 | 0.2% | 1.81 | 14 | 0.1% |
| AMMC_L | 0 | 0.0% | inf | 5 | 0.0% |
| upstream partner | # | NT | conns TRN_VP3a | % In | CV |
|---|---|---|---|---|---|
| l2LN22 (L) | 2 | GABA | 189.7 | 26.1% | 0.0 |
| TRN_VP3a (L) | 3 | ACh | 172.7 | 23.8% | 0.1 |
| v2LN4 (R) | 3 | ACh | 138 | 19.0% | 0.1 |
| lLN2F_b (L) | 2 | GABA | 62.7 | 8.6% | 0.8 |
| lLN2F_a (L) | 2 | GABA | 49.7 | 6.8% | 0.2 |
| lLN2T_b (L) | 2 | Unk | 22.3 | 3.1% | 0.5 |
| TRN_VP3b (L) | 1 | ACh | 20.3 | 2.8% | 0.0 |
| lLN2X05 (L) | 2 | Unk | 13.3 | 1.8% | 0.2 |
| lLN2X04 (L) | 2 | GABA | 10.7 | 1.5% | 0.3 |
| lLN2X11 (L) | 2 | 5-HT | 8.7 | 1.2% | 0.2 |
| lLN2X06 (L) | 1 | Unk | 7 | 1.0% | 0.0 |
| lLN2X12 (L) | 4 | ACh | 4.3 | 0.6% | 0.5 |
| OA-VUMa2 (M) | 2 | OA | 3 | 0.4% | 0.3 |
| CB1048 (L) | 2 | Glu | 2.7 | 0.4% | 0.8 |
| VP5+VP3_l2PN (L) | 1 | ACh | 2.3 | 0.3% | 0.0 |
| HRN_VP5 (L) | 3 | ACh | 2.3 | 0.3% | 0.5 |
| VP3+VP1l_ivPN (L) | 1 | ACh | 1.7 | 0.2% | 0.0 |
| VP3+_l2PN (L) | 2 | ACh | 1.7 | 0.2% | 0.2 |
| OA-VUMa5 (M) | 1 | OA | 1.3 | 0.2% | 0.0 |
| M_smPNm1 (R) | 1 | GABA | 1.3 | 0.2% | 0.0 |
| v2LNX01 (L) | 1 | Glu | 1.3 | 0.2% | 0.0 |
| v2LN49 (L) | 2 | Glu | 1 | 0.1% | 0.3 |
| CB1545 (L) | 1 | Glu | 0.7 | 0.1% | 0.0 |
| M_l2PN10t19b (R) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| VP5+_l2PN,VP5+VP2_l2PN (L) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| l2LN20 (L) | 1 | GABA | 0.7 | 0.1% | 0.0 |
| VP1l+VP3_ilPN (L) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| VP3+VP1l_ivPN (R) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| HRN_VP1l (L) | 2 | ACh | 0.7 | 0.1% | 0.0 |
| VP3+_l2PN (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| CB0010 (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| TRN_VP2 (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| l2LN23 (L) | 1 | Unk | 0.3 | 0.0% | 0.0 |
| v2LN4 (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| lLN1_a (L) | 1 | 5-HT | 0.3 | 0.0% | 0.0 |
| DNb05 (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| VP1m+VP5_ilPN (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| v2LN38 (L) | 1 | Unk | 0.3 | 0.0% | 0.0 |
| M_l2PNl20 (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| downstream partner | # | NT | conns TRN_VP3a | % Out | CV |
|---|---|---|---|---|---|
| VP3+_l2PN (L) | 3 | ACh | 899.3 | 31.9% | 0.5 |
| VP5+VP3_l2PN (L) | 1 | ACh | 337.7 | 12.0% | 0.0 |
| l2LN22 (L) | 2 | GABA | 241.7 | 8.6% | 0.1 |
| TRN_VP3a (L) | 3 | ACh | 172.7 | 6.1% | 0.0 |
| l2LN21 (L) | 1 | GABA | 166 | 5.9% | 0.0 |
| l2LN20 (L) | 2 | GABA | 144.7 | 5.1% | 0.1 |
| VP3+_l2PN (R) | 1 | ACh | 106.3 | 3.8% | 0.0 |
| lLN2T_b (L) | 2 | Unk | 100.7 | 3.6% | 0.3 |
| v2LN4 (L) | 3 | ACh | 94.3 | 3.3% | 0.2 |
| lLN2F_a (L) | 2 | GABA | 62.3 | 2.2% | 0.0 |
| DNb05 (L) | 1 | ACh | 61.7 | 2.2% | 0.0 |
| lLN2F_b (L) | 2 | GABA | 54 | 1.9% | 0.7 |
| VP1l+VP3_ilPN (R) | 1 | ACh | 45 | 1.6% | 0.0 |
| VP1l+VP3_ilPN (L) | 1 | ACh | 34.3 | 1.2% | 0.0 |
| v2LN4 (R) | 3 | ACh | 29 | 1.0% | 0.2 |
| MZ_lv2PN (L) | 1 | GABA | 28.3 | 1.0% | 0.0 |
| lLN2X11 (L) | 2 | 5-HT | 26 | 0.9% | 0.4 |
| lLN2X04 (L) | 2 | GABA | 25 | 0.9% | 0.1 |
| M_l2PN10t19b (R) | 1 | ACh | 16.7 | 0.6% | 0.0 |
| VP5+Z_adPN (L) | 1 | ACh | 12 | 0.4% | 0.0 |
| VP3+VP1l_ivPN (R) | 1 | ACh | 12 | 0.4% | 0.0 |
| M_l2PN10t19b (L) | 1 | ACh | 11 | 0.4% | 0.0 |
| VP5+_l2PN,VP5+VP2_l2PN (L) | 3 | ACh | 9.7 | 0.3% | 1.1 |
| lLN2X05 (L) | 2 | Unk | 9 | 0.3% | 0.3 |
| M_l2PNm16 (L) | 2 | ACh | 8.7 | 0.3% | 0.3 |
| CB1545 (L) | 1 | Glu | 8.3 | 0.3% | 0.0 |
| TRN_VP3b (L) | 1 | ACh | 7.3 | 0.3% | 0.0 |
| M_smPNm1 (R) | 1 | GABA | 7 | 0.2% | 0.0 |
| VP3+VP1l_ivPN (L) | 1 | ACh | 6.3 | 0.2% | 0.0 |
| lLN2X12 (L) | 3 | ACh | 6.3 | 0.2% | 0.1 |
| VP3+_vPN (L) | 1 | GABA | 6 | 0.2% | 0.0 |
| v2LN31 (L) | 1 | Glu | 5.7 | 0.2% | 0.0 |
| v2LN38 (R) | 2 | Unk | 5.7 | 0.2% | 0.5 |
| v2LN49 (L) | 2 | Glu | 5.3 | 0.2% | 0.0 |
| CB1048 (L) | 2 | Glu | 4.7 | 0.2% | 0.3 |
| AL-AST1 (L) | 1 | ACh | 4.3 | 0.2% | 0.0 |
| lLN2P_c (L) | 2 | GABA | 4 | 0.1% | 0.7 |
| lLN1_a (L) | 2 | 5-HT | 4 | 0.1% | 0.0 |
| lLN1_bc (L) | 6 | Unk | 3.7 | 0.1% | 0.8 |
| SAD009 (L) | 1 | ACh | 2.7 | 0.1% | 0.0 |
| v2LN38 (L) | 1 | Unk | 2.7 | 0.1% | 0.0 |
| v2LN33 (L) | 2 | Glu | 2.7 | 0.1% | 0.5 |
| lLN2X03 (L) | 2 | 5-HT | 2.3 | 0.1% | 0.4 |
| M_l2PNm17 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| CB2571 (L) | 2 | Unk | 2 | 0.1% | 0.7 |
| lLN2X06 (L) | 1 | Unk | 1.7 | 0.1% | 0.0 |
| v2LN34E (L) | 2 | Glu | 1.7 | 0.1% | 0.2 |
| ALON1 (L) | 1 | ACh | 1.7 | 0.1% | 0.0 |
| CB3417 (L) | 2 | Unk | 1.7 | 0.1% | 0.6 |
| ALON2 (L) | 1 | ACh | 1.3 | 0.0% | 0.0 |
| HRN_VP5 (L) | 3 | ACh | 1.3 | 0.0% | 0.4 |
| CL113 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| M_l2PN3t18 (L) | 2 | ACh | 1 | 0.0% | 0.3 |
| vLN25 (L) | 1 | Glu | 0.7 | 0.0% | 0.0 |
| CB0010 (R) | 1 | GABA | 0.7 | 0.0% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 0.7 | 0.0% | 0.0 |
| M_l2PNm15 (L) | 1 | ACh | 0.7 | 0.0% | 0.0 |
| OA-VUMa5 (M) | 1 | OA | 0.7 | 0.0% | 0.0 |
| lLN2P_b (L) | 1 | GABA | 0.7 | 0.0% | 0.0 |
| M_vPNml65 (L) | 1 | GABA | 0.7 | 0.0% | 0.0 |
| lLN2P_a (L) | 1 | Unk | 0.7 | 0.0% | 0.0 |
| M_ilPNm90,M_ilPN8t91 (R) | 1 | ACh | 0.7 | 0.0% | 0.0 |
| CB2527 (L) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| lLN2T_e (L) | 1 | Unk | 0.3 | 0.0% | 0.0 |
| VP1m+_lvPN (L) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| CB0316 (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| M_lPNm11A (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| v2LNX01 (L) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| CB3575 (L) | 1 | Unk | 0.3 | 0.0% | 0.0 |
| VP1m+VP5_ilPN (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| TRN_VP2 (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| ORN_VL1 (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |